Figure 1.
EGFR-TK-selective inhibitors; gefitinib, erlotinib and AEE788 and EGFR/HER2-TK-dual inhibitor; lapatinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.